GTS Securities’s Korro Bio KRRO Stock Holding History

GTS Securities’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,466	Closed	-$77.3K	–	4024
2023 Q2	$77.3K	Buy	+4,466	New	+$86.6K	﹤0.01%	1116

Other funds holding KRRO

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GTS Securities's KRRO Position: Q3 2023 in Review

GTS Securities sold out of Korro Bio (KRRO) in Q3 2023, closing a stake of 4,466 shares — an estimated $77.3K sold.

GTS Securities first reported a position in KRRO in Q2 2023 and held it in 1 quarter. The position peaked at $77.3K in Q2 2023. 41 funds tracked by Wall St. Rank hold KRRO as of Q3 2023.

GTS Securities reported no remaining Korro Bio position as of Q3 2023 after selling out during the quarter.
GTS Securities sold 4,466 Korro Bio shares in Q3 2023, an estimated $77.3K.
GTS Securities first reported a position in Korro Bio in Q2 2023 and held it in 1 quarter.
GTS Securities's Korro Bio position peaked at $77.3K in Q2 2023.
41 funds tracked by Wall St. Rank held Korro Bio as of Q3 2023.

Based on GTS Securities's 13F filing for Q3 2023, filed 15 Nov 2023.